ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1248

Prevalence Of Vitamin D Inadequacy In European Postmenopausal Women Aged Over 80 Years

Olivier Bruyere1, Justine Slomian1, Charlotte Beaudart2, Fanny Buckinx3, Etienne Cavalier4, Sophie Gillain5, Jean Petermans5 and Jean-Yves Reginster1, 1Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium, 2Public Health/Epidemiology, University of Liège, Liège, Belgium, 3Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium, 4Department of Clinical Chemistry, CHU de Liege, Liege, Belgium, 5Geriatric Department, CHU de Liege, Liege, Belgium

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Vitamin D and menopause

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Osteoporosis and Metabolic Bone Disease: Clinical Aspects and Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Inadequate vitamin D level is associated with secondary hyperparathyroidism and increased bone turnover and bone loss, which in turn increases fracture risk. The objective of this study is to assess the prevalence of inadequate serum vitamin D levels in postmenopausal European women aged over 80 years. There are no clear international agreements on what constitutes a level of vitamin D inadequacy, but recent publications suggest that the circulating level of vitamin D should be over 75 nmol/L or at least between 50 and 75 nmol/L.

Methods:

Assessment of 25-hydroxyvitamin D [25(OH)D] was performed in 8532 European postmenopausal women with osteoporosis or osteopenia of which 1984 were aged over 80 years. European countries included France, Belgium, Denmark, Italy, Poland, Hungary, United Kingdom, Spain and Germany. Two cut-offs of 25(OH)D inadequacy were fixed : < 75 nmol/L and < 50 nmol/L.

Results:

Mean (SD) age of the patients was 83.4 (2.9) years, body mass index was 25.0 (4.0) kg/m². Level of 25(OH)D was 53.3 (26.7) nmol/L. There was a highly significant difference of 25(OH)D level across European countries ( p < 0.0001) with the lowest level of 25(OH)D found in France [47.7 (26.4) nmol/L]. In these women aged over 80 years, the prevalence of 25(OH)D inadequacy was 88.6% and 53.4% when considering cut-offs of 75 and 50 nmol/L, respectively.  In the 397 (20.0%) patients taking supplemental vitamin D with or without supplemental calcium, the mean serum 25-OH-D level was significantly higher than in the other patients (65.2 (29.2) nmol/L vs. 50.3 (25.2) nmol/L ; P < 0.001).

Conclusion:

This study indicates a high prevalence of vitamin D [25(OH)D] inadequacy in old European women. The prevalence could be even higher in some particular countries. A greater awareness of the importance of vitamin D inadequacy is needed to address this public health problem.


Disclosure:

O. Bruyere,
None;

J. Slomian,
None;

C. Beaudart,
None;

F. Buckinx,
None;

E. Cavalier,
None;

S. Gillain,
None;

J. Petermans,
None;

J. Y. Reginster,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-of-vitamin-d-inadequacy-in-european-postmenopausal-women-aged-over-80-years/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology